CClinicalTrials.gg
Status unknownNCT04805580Updated Apr 6, 2021

Qudratus Lumborum Block Versus Unilateral Intrathecal Block for Inguinal Hernia Repair

An interventional study of unilateral intrathecal block in Inguinal Hernia,Quadratus Lumborum Block , Unilateral Intrathecal Block, sponsored by Zagazig University. Status unknown. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-06.

Sponsored by Zagazig University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

compare between Quadratus lumborum block and unilateral intrathecal block for patients undergoing inguinal hernia repair regarding the quality of anesthesia and hemodynamic stability of patients.

Read the detailed description

comparison between unilateral intrathecal block anesthesia (unilateral SA) and Quadratus lumborum block for inguinal hernia repair unilateral intrathecal block is widely used nowadays for unilateral inguinal hernia repair, providing intense sensory and motor blockade. Limiting the block to the operative site by using small doses of hyperbaric solutions injected slowly through a directional needle and maintaining a lateral decubitus position for a certain duration has been proposed, to produce high quality, long-duration analgesia, with minimal hemodynamic adverse events.

Previous case report studies stated that we can use Quadratus Lumborum Block as the sole anesthetic technique for open hernia repair.

02

Conditions studied

  • Inguinal Hernia,Quadratus Lumborum Block , Unilateral Intrathecal Block
03

In context

Hernia

1,096 studies on the registry are indexed under Hernia; 132 are open to participants now.

This study's planned enrollment of 50 is below the median of 80 across 739 interventional studies indexed under Hernia.

Browse Hernia studies →

Lead sponsor

Zagazig University is the lead sponsor of 447 studies on the registry; 75 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • physical status ASA: I-II BMI >18kg/m2\<30kg/m2 written informed consent from the patient scheduled for open unilateral inguinal hernia repair

Exclusion criteria

Exclusion Criteria:

  • uncooperative patient
  • Allergy to local anesthetic drugs
  • patients on chronic alcohol, opioid, tranquilizer or sedative use
  • Pregnant females.
  • Psychological, mental disorders, or depression.
  • Patients receiving anticoagulants therapy or suspected coagulopathy.
  • Patients with infection or previous surgery at sit of anesthetic procedures.
  • Patients with significant cardiovascular, respiratory, renal, hepatic, or metabolic disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    intrathecal block

    patients (25) will receive unilateral intrathecal block using 1.5 ml of hyperbaric bupivacaine

    Procedure: unilateral intrathecal block

  • Active comparator
    Quadratus lumborum block

    patients (25) will receive quadratus lumborum block by an anterior approach using 30 ml of bupivacaine 0.25%

    Procedure: unilateral intrathecal block

Interventions

  • Procedureunilateral intrathecal block

    Quadratus lunborum block

    Also known as: unilateral spinal anaesthesia

06

What researchers measure

Primary outcomes

  1. To assess safety of quadratus lumborum block vs unilateral intrathecal block for inguinal hernia repair: complications of the block

    complications of the block in each group like inadequate blockade detected by increased dose of sedation required in this group ,hemodynamic instability related to the block detected by frequent monitoring of the blood pressure and heart rate

    Time frame: 2 hours

Secondary outcomes

  1. To compare the onset and duration of sensory block between both blocks

    the onset of pin brick discrimination and time of first request of analgesics after block performance in each group

    Time frame: 12 hours

  2. To compare the time to ambulation

    the time till the patient succeed in ambulation

    Time frame: 24 hours

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Favaro ML, Gabor S, Souza DBF, Araujo AA, Milani ALC, Ribeiro Junior MAF. Quadratus Lumborum Block As A Single Anesthetic Method For Laparoscopic Totally Extraperitoneal (Tep) Inguinal Hernia Repair: A Randomized Clinical Trial. Sci Rep. 2020 May 22;10(1):8526. doi: 10.1038/s41598-020-65604-x. PubMed 32444629 ↗
  • La Colla L, La Colla MDL, Schroeder R, Schroeder RMD. Quadratus Lumborum Block as Sole, Homeostatic-Preserving Anesthetic for a Patient with Multiple System Atrophy Undergoing Open Inguinal Hernia Repair: A Case Report. Case Rep Anesthesiol. 2018 Jun 28;2018:7161860. doi: 10.1155/2018/7161860. eCollection 2018. Erratum In: Case Rep Anesthesiol. 2018 Aug 19;2018:8316750. doi: 10.1155/2018/8316750.. La Colla MDL [corrected to La Colla L], Schroeder RMD [corrected to Schroeder R]. PubMed 30050698 ↗
  • Isil CT, Cinar AS, Oba S, Isil RG. Comparison of Spinal Anaesthesia and Paravertebral Block in Unilateral Inguinal Hernia Repair. Turk J Anaesthesiol Reanim. 2014 Oct;42(5):257-63. doi: 10.5152/TJAR.2014.75508. Epub 2014 Jul 9. PubMed 27366432 ↗

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Csr

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04805580
Lead sponsor
Zagazig University
Responsible party
Hala mohamed Rashad mohamed (principal investigator, Zagazig University) — Principal investigator
First posted
Mar 18, 2021
Start date
May 2021 (estimated)
Primary completion
Sep 2021 (estimated)
Completion
Oct 2021 (estimated)
Last update
Apr 6, 2021

Study contacts

Hala Rashad
Contact
rashad_hala@yahoo.com
+201148737769
Asmaa El-Deen=
Contact
asmaa_galal79@yahoo.com
+21271550089

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion